Wolverine Asset Management’s SBC Medical Group SBC Stock Holding History

Wolverine Asset Management’s Portfolio SBC Stock Details SBC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-216,642	Closed	-$2.33M	–	1915
2023 Q4	$2.33M	Sell	216,642 -672	-0.3%	-$7.19K	0.02%	510
2023 Q3	$2.32M	Sell	217,314 -7,215	-3%	-$76K	0.03%	511
2023 Q2	$2.31M	Buy	224,529 +13,155	+6%	+$136K	0.03%	474
2023 Q1	$2.21M	Sell	211,374 -190,802	-47%	-$1.97M	0.03%	493
2022 Q4	$4.1M	Buy	402,176 +39,900	+11%	+$404K	0.04%	387
2022 Q3	$3.63M	Buy	+362,276	New	+$3.62M	0.04%	397

Other funds holding SBC

Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return

Walleye Trading New York $87.6B AUM 68.17% 1-Year Est. Return

Meteora Capital Boca Raton, Florida $1.36B AUM 21.19% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

TCM

Tuttle Capital Management Riverside, Connecticut $148M AUM 64.07% 1-Year Est. Return

Wolverine Asset Management's SBC Position: Q1 2024 in Review

Wolverine Asset Management sold out of SBC Medical Group (SBC) in Q1 2024, closing a stake of 216,642 shares — an estimated $2.33M sold.

Wolverine Asset Management first reported a position in SBC in Q3 2022 and held it in 6 quarters. The position peaked at $4.1M in Q4 2022. 5 funds tracked by Wall St. Rank hold SBC as of Q1 2024.

Wolverine Asset Management reported no remaining SBC Medical Group position as of Q1 2024 after selling out during the quarter.
Wolverine Asset Management sold 216,642 SBC Medical Group shares in Q1 2024, an estimated $2.33M.
Wolverine Asset Management first reported a position in SBC Medical Group in Q3 2022 and held it in 6 quarters.
Wolverine Asset Management's SBC Medical Group position peaked at $4.1M in Q4 2022.
5 funds tracked by Wall St. Rank held SBC Medical Group as of Q1 2024.

Based on Wolverine Asset Management's 13F filing for Q1 2024, filed 13 May 2024.